246 related articles for article (PubMed ID: 5350786)
1. The effects of 2-(2,6-dichlorphenylamine)-2-imidazoline hydrochloride (Catapres) upon the systemic and coronary haemodynamics and metabolism of intact dogs.
Maxwell GM
Arch Int Pharmacodyn Ther; 1969 Sep; 181(1):7-14. PubMed ID: 5350786
[No Abstract] [Full Text] [Related]
2. The effects of a new beta-adrenergic stimulator (saligenin, AH3365) on the general and coronary haemodynamics and metabolism of the intact dog.
Maxwell GM; Rencis V; Harvey G
Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):341-8. PubMed ID: 5371185
[No Abstract] [Full Text] [Related]
3. Effect of the hypotensive drug ST 155 (Catapres) on the heart and peripheral circulation.
Nayler WG; Price JM; Swann JB; McInnes I; Race D; Lowe TE
J Pharmacol Exp Ther; 1968 Nov; 164(1):45-59. PubMed ID: 5722106
[No Abstract] [Full Text] [Related]
4. Comparison between the effects of ST 600 and catapres.
Kho TL; Schalekamp MA; Zaal GA; Wester A; Birkenhäger WH
Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):347-50. PubMed ID: 1156039
[TBL] [Abstract][Full Text] [Related]
5. [Hemodynamic effects of ST 155, 2-(2,6 dichlorophenylamino)-2 imidazoline hydrochloride, in hypertensive dogs].
Laubie M; Schmitt H
Arch Int Pharmacodyn Ther; 1969 May; 179(1):23-5. PubMed ID: 5348396
[No Abstract] [Full Text] [Related]
6. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics.
Petta JM; Zaccheo VJ
J Pharmacol Exp Ther; 1971 Feb; 176(2):328-38. PubMed ID: 4998691
[No Abstract] [Full Text] [Related]
7. The effects of acute catecholamine release by guanoxan upon the myocardial metabolism of the intact dog.
Maxwell GM; Kneebone GM
Arch Int Pharmacodyn Ther; 1968 Nov; 176(1):149-56. PubMed ID: 5709780
[No Abstract] [Full Text] [Related]
8. The effect of 1,1-(2,7-dimorphocino-6-phenyl-4-pteridinyl-imino) di-2-propanol (RE102), a dipyridamol derivative, upon the general and cardiac haemodynamics of the intact dog.
Maxwell GM
Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):444-9. PubMed ID: 5348412
[No Abstract] [Full Text] [Related]
9. [Haemodynamics, myocardial mechanics, oxygen requirement and oxygenation of the human heart during induction of anaesthesia with etomidate (author's transl)].
Kettler D; Sonntag H; Donath U; Regensburger D; Schenk HD
Anaesthesist; 1974 Mar; 23(3):116-21. PubMed ID: 4460735
[No Abstract] [Full Text] [Related]
10. Comparison between the effects of ST 600 and clonidine.
Kho TL; Schalekamp MA; Zaal GA; Wester A; Birkenhäger WH
Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):162-9. PubMed ID: 1190909
[TBL] [Abstract][Full Text] [Related]
11. Effect of endotoxin on myocardial performance.
Hinshaw LB; Archer LT; Greenfield LJ; Miller JA; Guenter CA
J Trauma; 1972 Dec; 12(12):1056-62. PubMed ID: 4568504
[No Abstract] [Full Text] [Related]
12. The effects of lidocaine on systemic and coronary hemodynamics.
Thomsen JH; Terry W; Stenlund RR; Querimit S; Rowe GG
Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):83-92. PubMed ID: 5123869
[No Abstract] [Full Text] [Related]
13. Hemodynamic effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) at rest and during exercise with special respect to the pulmonary circulation.
Koch G
Arzneimittelforschung; 1971 Jan; 21(1):57-61. PubMed ID: 5108382
[No Abstract] [Full Text] [Related]
14. Study of the action of the N-methyl-N'-yohimbohydrazide on general metabolism and respiration and on systemic hemodynamics.
Pham-Huu-Chanh ; Patte J; Saint-Ruff G
Arzneimittelforschung; 1973 Aug; 23(8):1014-6. PubMed ID: 4801017
[No Abstract] [Full Text] [Related]
15. The influence of epsilon aminocaproic acid on cardiac performance. An experimental study in dogs.
Hoie J; Sykes BJ; Schenk WG
J Thorac Cardiovasc Surg; 1971 Aug; 62(2):255-61. PubMed ID: 5560508
[No Abstract] [Full Text] [Related]
16. Prevention and reversal of myocardial failure in endotoxin shock.
Hinshaw LB; Archer LT; Black MR; Greenfield LJ; Guenter CA
Surg Gynecol Obstet; 1973 Jan; 136(1):1-11. PubMed ID: 4565872
[No Abstract] [Full Text] [Related]
17. Hemodynamic activity of L 6150. Systemic and coronary circulation.
Sardi A; Caravaggi AM; Baldoli E
Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(3):301-12. PubMed ID: 4270747
[No Abstract] [Full Text] [Related]
18. Pharmacological studies of a newly synthetized 1,4-dihydropyridine derivative, 2,6-dimethyl-3,5-dimethoxycarbonyl-4- (o-difluoromethoxyphenyl)-1,4-dihydropyridine (PP-1466).
Toribatake T; Fujii K; Kobayashi M; Okumura M; Aikawa K
Arzneimittelforschung; 1985; 35(4):680-6. PubMed ID: 4015734
[TBL] [Abstract][Full Text] [Related]
19. Systemic and coronary hemodynamic effects of perhexiline.
Rowe GG; Spring DA; Afonso S
Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):377-93. PubMed ID: 4921275
[No Abstract] [Full Text] [Related]
20. Systemic and coronary hemodynamic effects of isoproterenol in control animals and those pretreated with a MAO inhibitor (pargyline hydrochloride).
McKenna DH; Afonso S; Jaramillo CV; Crumpton CW; Rowe GG
Arch Int Pharmacodyn Ther; 1966 Aug; 162(2):275-82. PubMed ID: 5968511
[No Abstract] [Full Text] [Related]
[Next] [New Search]
